Dr. Nackel founded Three-Sixty Advisory Group, LLC (Three-Sixty) in 2007 to help emerging health care services and medical technology companies address growth, performance, and capital challenges.
In 2018, he founded Wavemaker Three-Sixty Health (Wavemaker 360) which is a health-care dedicated early-stage venture fund.
Prior to Wavemaker 360, Dr. Nackel served as the chief executive officer of Ingenix Consulting (now Optum), a United Health Group (NYSE: UNH) company.
He was global managing director of health services at Ernst and Young (now EY) for 25 years and was also the CEO of Sogeti North America, the professional services division of CapGemini.
Dr. Nackel currently serves on the board of directors of the Pennant Group (NASDAQ: PNTG) which provides home health, hospice and assisted living services. Previously he served for 12 years on the board of the Ensign Group, Inc., (NASDAQ: ENSG) which provides skilled nursing and rehabilitative services and Mercury General (NYSE: MCY), a specialty writer of all risk classifications of automotive insurance.
He earned his bachelor's degree in mathematics and economics from Tufts University, master's degrees in public health and industrial engineering, and a Ph.D. in industrial engineering and health administration from the University of Missouri.
Savonix offers digital neuropsychology platform.
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'
IVFMD physicians named 2025 Castle Connolly Top Doctors
HOPE Therapeutics and NRx Pharmaceuticals select BTIG as financial advisor
Partillion Bioscience opens pre-orders for Nanovial Multicell Assay Antibody Discovery Kits
Champions Oncology expands bioanalytical services with new technology
Petauri's Nicole Lodowski named to MM+M's 40 Under 40 for 2025
WuXi XDC Cayman wins 'Best CDMO' at World ADC Awards 2024
Nektar Therapeutics agrees sale of Huntsville manufacturing facility and reagent supply business